This study assessed the cost–effectiveness of seven different screening strategies for patients with chronic hepatitis B (CHB) in China: ultrasonography (US), alpha-fetoprotein (AFP), protein induced by vitamin K absence-II (PIVKA-II), AFP+US, AFP+PIVKA-II, GAAD and GAAD+US. The gene discussed is AFP; the disease is chronic hepatitis B virus infection.